Literature DB >> 17468345

Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions.

Andrea Mari1, Kristine Degn, Birgitte Brock, Joergen Rungby, Ele Ferrannini, Ole Schmitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17468345     DOI： 10.2337/dc07-0310

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  26 in total

Review 1.  The efficacy and safety of liraglutide.

Authors:  Kyeong-Hye Jeong; Bong Kyu Yoo
Journal:  Int J Clin Pharm       Date:  2011-09-28

2.  Regulation of adipocyte formation by GLP-1/GLP-1R signaling.

Authors:  Tenagne Delessa Challa; Nigel Beaton; Myrtha Arnold; Gottfried Rudofsky; Wolfgang Langhans; Christian Wolfrum
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

Review 3.  Liraglutide: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Caroline M Perry
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

4.  Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.

Authors:  Sun H Kim; Alice Liu; Danit Ariel; Fahim Abbasi; Cindy Lamendola; Kaylene Grove; Vanessa Tomasso; Gerald Reaven
Journal:  Diabetologia       Date:  2013-12-11       Impact factor: 10.122

5.  Role and development of GLP-1 receptor agonists in the management of diabetes.

Authors:  Chee W Chia; Josephine M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2009-05-15       Impact factor: 3.168

6.  Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives.

Authors:  Mahamood Edavalath; Jeffrey W Stephens
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

7.  Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.

Authors:  Anne Flint; Khalil Nazzal; Pawel Jagielski; Charlotte Hindsberger; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

Review 8.  Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes.

Authors:  Richard E Pratley
Journal:  Medscape J Med       Date:  2008-07-28

9.  Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors.

Authors:  Richard E Pratley; Matthew Gilbert
Journal:  Rev Diabet Stud       Date:  2008-08-10

10.  Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).

Authors:  M Marre; J Shaw; M Brändle; W M W Bebakar; N A Kamaruddin; J Strand; M Zdravkovic; T D Le Thi; S Colagiuri
Journal:  Diabet Med       Date:  2009-03       Impact factor: 4.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.